Greene Jean Selden 4

4 · Amneal Pharmaceuticals, Inc. · Filed May 8, 2019

Form 4

Period: 2019-05-06

Director

Transactions

Award
Stock Option
2019-05-06+28,044→ 28,044 total
Exercise: $14.05Exp: 2029-05-06→ Class A Common Stock (28,044 underlying)
Exercise/Conversion
Restricted Stock Units
2019-05-08−6,107→ 0 total
→ Class A Common Stock (6,107 underlying)
Exercise/Conversion
Class A Common Stock
2019-05-08+6,107→ 6,107 total
Award
Restricted Stock Units
2019-05-06+6,459→ 6,459 total
→ Class A Common Stock (6,459 underlying)

Footnotes (4)

[F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
[F2]The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
[F3]Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units have no expiration date.
[F4]On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019.

Documents

2 files